Baseline knowledge and receptiveness to genetic testing for hereditary breast and ovarian cancer syndromes in Chinese high-risk females

被引:6
作者
Chu, Annie Tsz-Wai [1 ,2 ]
Tse, Desiree Man-Sik [3 ]
Suen, Dacita To Ki [1 ]
Kwong, Ava [1 ,2 ,4 ,5 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Div Breast Surg, Dept Surg, Hong Kong, Peoples R China
[2] Hong Kong Hereditary Breast Canc Family Registry, Hong Kong, Peoples R China
[3] Univ Hong Kong, Li Ka Shing Fac Med, Dept Family Med & Primary Care, Hong Kong, Peoples R China
[4] Hong Kong Sanat & Hosp, Dept Surg, Hong Kong, Peoples R China
[5] Univ Hong Kong, Dept Surg, Shenzhen Hosp, Hong Kong, Peoples R China
关键词
Hereditary breast cancer; Genetic counselling; BRCA1; 2; Chinese; Genetic testing; POPULATION-BASED SAMPLE; FAMILY-HISTORY; BRCA; MUTATION; MANAGEMENT; BARRIERS; OLAPARIB; WOMEN;
D O I
10.1007/s12687-021-00518-3
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Limited studies have examined the pre-counselling knowledge and attitudes of high-risk women on hereditary breast and ovarian cancer (HBOC) syndromes genetic screening in Asia Pacific regions, particularly among Chinese. After controlling cost, an intrinsic barrier to undertake such screening, comprehensive understanding of the baseline characteristics of this cohort towards HBOC genetic counselling and testing service (GT) could be sought. This study aimed at exploring the baseline knowledge, possible motivators, barriers, and decisional factors of undertaking such service. One hundred and forty-two Southern Hong Kong Chinese high-risk females (89.4% with cancer history; 10.6% were cancer-free at-risk family members) completed a questionnaire right before their pre-testing GT. Results showed that perceived benefits to self and family members with reference to cancer prevention are important decisional motivators. A sponsored cancer genetic testing service in this cohort was crucial as 71.3% would not have opted for self-financed screening. Pre-testing and post-testing counselling were essential, particularly for older and less educated high-risk individuals. More importantly, after thorough pre-counselling with Q&A session, the entire cohort in this study gave written consent to undertake GT. Moreover, those proven to be germline pathogenic variant carriers were willing to share the information with family members and successfully persuaded them to pursue GT.
引用
收藏
页码:431 / 438
页数:8
相关论文
共 31 条
[1]   Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[2]   Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population The ABOUT Study [J].
Armstrong, Joanne ;
Toscano, Michele ;
Kotchko, Nancy ;
Friedman, Sue ;
Schwartz, Marc D. ;
Virgo, Katherine S. ;
Lynch, Kristian ;
Andrews, James E. ;
Loi, Claudia X. Aguado ;
Bauer, Joseph E. ;
Casares, Carolina ;
Clark, Elizabeth Bourquardez ;
Kondoff, Matthew R. ;
Molina, Ashley D. ;
Abdollahian, Mehrnaz ;
Walker, Gregg ;
Sutphen, Rebecca .
JAMA ONCOLOGY, 2015, 1 (09) :1251-1260
[3]  
Census and Statistics Department, 2018, HONG KONG FIG
[4]   Establishing a cancer genetics programme in Asia - The Singapore experience [J].
Chieng W.-S. ;
Lee S.-C. .
Hereditary Cancer in Clinical Practice, 4 (3) :126-135
[5]   Acceptance, motivators, and barriers in attending breast cancer genetic counseling in Asians [J].
Chin, TM ;
Tan, SH ;
Lim, SE ;
Iau, P ;
Yong, WP ;
Wong, SW ;
Lee, SC .
CANCER DETECTION AND PREVENTION, 2005, 29 (05) :412-418
[6]   "Decoding hereditary breast cancer" benefits and questions from multigene panel testing [J].
Colas, Chrystelle ;
Golmard, Lisa ;
de Pauw, Antoine ;
Caputo, Sandrine M. ;
Stoppa-Lyonnet, Dominique .
BREAST, 2019, 45 :29-35
[7]  
Coyle Yvonne M., 2009, V472, P25, DOI 10.1007/978-1-60327-492-0_2
[8]   Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer [J].
Cragun, D. ;
Bonner, D. ;
Kim, J. ;
Akbari, M. R. ;
Narod, S. A. ;
Gomez-Fuego, A. ;
Garcia, J. D. ;
Vadaparampil, S. T. ;
Pal, Tuya .
BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (01) :169-176
[9]   Racial Disparities in BRCA Testing and Cancer Risk Management Across a Population-Based Sample of Young Breast Cancer Survivors [J].
Cragun, Deborah ;
Weidner, Anne ;
Lewis, Courtney ;
Bonner, Devon ;
Kim, Jongphil ;
Vadaparampil, Susan T. ;
Pal, Tuya .
CANCER, 2017, 123 (13) :2497-2505
[10]   Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy [J].
Domchek, Susan M. ;
Aghajanian, Carol ;
Shapira-Frommer, Ronnie ;
Schmutzler, Rita K. ;
Audeh, M. William ;
Friedlander, Michael ;
Balmana, Judith ;
Mitchell, Gillian ;
Fried, Georgeta ;
Stemmer, Salomon M. ;
Hubert, Ayala ;
Rosengarten, Ora ;
Loman, Niklas ;
Robertson, Jane D. ;
Mann, Helen ;
Kaufman, Bella .
GYNECOLOGIC ONCOLOGY, 2016, 140 (02) :199-203